Clinical Trial Update: Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 [Phase 3]

View source ↗

Summary

Phase 3 trial comparing an oral weekly islatravir/lenacapavir regimen with standard of care in virologically suppressed people with HIV-1; the study status is A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Islatravir (Islatravir)
• Lenacapavir (lenacapavir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-Infection | Phase 3 | Status: ACTIVE_NOT_RECRUITING